As mentioned above, some DUBs promote the onset and progression of AD by regulating autophagy, proteasome degradation, endoplasmic reticulum stress, etc. suggesting that DUB inhibitors hold significant potential in the treatment of AD and other neurodegenerative disorders. Here, ZUP1 is linked to Alzheimer disease.